Research Topics
| Gunjan Y GandhiSummaryAffiliation: Mayo Clinic Country: USA Publications
|
Detail Information
Publications
Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patientsGunjan Y Gandhi
Department of Internal Medicine and Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 80:862-6. 2005..To estimate the magnitude of association between intraoperative hyperglycemia and perioperative outcomes in patients who underwent cardiac surgery...
Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials.7Gunjan Y Gandhi
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:418-30. 2008..To conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the effect of perioperative insulin infusion on outcomes important to patients...
Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trialsGunjan Y Gandhi
Division of Endocrinology, Mayo Clinic, Jacksonville, Florida 32224, USA
J Diabetes Sci Technol 5:952-65. 2011..We conducted a systematic review and meta-analysis to assess the efficacy of continuous glucose monitoring (CGM) in improving glycemic control and reducing hypoglycemia compared to self-monitored blood glucose (SMBG)...
Endocrinopathy in POEMS syndrome: the Mayo Clinic experienceGunjan Y Gandhi
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:836-42. 2007..To determine the prevalence and characteristics of endocrinopathies at diagnosis of POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) syndrome...
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trialGunjan Y Gandhi
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Ann Intern Med 146:233-43. 2007..It is not known whether rigorous intraoperative glycemic control reduces death and morbidity in cardiac surgery patients...
Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survivalGunjan Y Gandhi
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 81:1034-40. 2006..To determine the temporal trends in prevalence of confirmed diabetes mellitus (DM), time from the date DM criteria were met to myocardial infarction (MI), and impact of DM on survival...
Glycemic control in the medical intensive care unitMichelle A Kovalaske
Mayo Clinic Division of Endocrinology and Metabolism, Jacksonville, Florida 32224, USA
J Diabetes Sci Technol 3:1330-41. 2009..It also remains to be seen if tight glucose control is beneficial once hypoglycemia is minimized with technological advances such as continuous glucose monitoring systems...
Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgeryBrad S Karon
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Am J Clin Pathol 127:919-26. 2007..Capillary whole blood glucose levels correlate most closely with laboratory plasma glucose levels in patients receiving intensive intravenous insulin therapy after cardiac surgery...
Patient-important outcomes in registered diabetes trialsGunjan Y Gandhi
Division of Endocrinology, Diabetes, Metabolism and Nutrition, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
JAMA 299:2543-9. 2008....
Incretins in the ICU: is insulin on its way out?Michelle A Kovalaske
Division of Endocrinology and Metabolism, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL32224, USA
Crit Care 13:161. 2009..While promising, additional research is required studying effects on hard clinical endpoints...
Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trialsGunjan Y Gandhi
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Clin Endocrinol (Oxf) 69:244-52. 2008..We conducted a systematic review and meta-analysis to determine the efficacy of nonantigen-based immunotherapeutic approaches for preservation of beta-cell function in patients with type 1 diabetes...
Patient-important outcomes in diabetes--time for consensusVictor M Montori
Knowledge and Encounter Research Unit, Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Lancet 370:1104-6. 2007
Glycemic durability of monotherapy for diabetesGunjan Y Gandhi
N Engl J Med 356:1379-80; author reply 1380. 2007
